Heres How Nutrition Helps You Get the Most Out of Your Medication: 1) Prioritize Protein GLP-1s reduce appetite and with less food, you risk losing muscle along with fat
First, coders must consider the type of diabetes, the etiology of secondary diabetes, and diabetic complications
Compounded GLP-1 Preparations (Not FDA-Approved) Considered only when an FDA-approved alternative is unavailable or clinically inappropriate for an individual patient (503A) or supplied for office use where permitted by law
While the drug is largely eliminated within 5 weeks of the last dose, the pharmacodynamic effectsthe actual clinical impact on blood glucose and appetitemay begin to wane earlier as concentrations fall below therapeutic thresholds
Discontinuation is a valid choice when symptoms exceed the benefit
Though several molecules, such as mazdutide, a GLP/glucagon dual agonist, are being studied in various phases, the first agent targeting incretins other than just GLP-1 was approved in 2022 tirzepatide [41]